Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells

Biochemical Journal

Volumn 355, Issue 2, 2001, Pages 307-314

  Kasza, A ^a   Rogowski, K ^a   Kilarski, W ^a   Sobota, R ^a   Bernas, T ^a   Dobrucki, J ^a   Travis, J ^a   Koj, A ^a   Bugno, M ^a   Kordula, T ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Autocrine stimulation; Cytokine receptors; Cytokines; Signalling

Indexed keywords

CELLS; ENZYME INHIBITION; POLYPEPTIDES;

ENDOPLASMIC RETICULUM (ER);

BIOCHEMISTRY;

JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ARTICLE; ASTROCYTOMA CELL; AUTOCRINE EFFECT; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANTIGENS, CD; ASTROCYTOMA; BASE SEQUENCE; CYTOKINE RECEPTOR GP130; DNA PRIMERS; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; ONCOSTATIN M; PEPTIDES; PROTEIN-TYROSINE KINASES; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035870911     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3550307     Document Type: Article

References (41)

1. Private and public autocrine loops in neoplastic cells
2. Autocrine stimulation by erythropoietin (Epo) requires Epo secretion
3. Intracellular murine IFN-γ mediates virus resistance, expression of oligoadenylate synthetase, and activation of STAT transcription factors
4. COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth
5. Transformation by v-sis occurs by an internal autoactivation mechanism
6. Intracellular retention of interleukin-6 abrogates signaling
7. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M
8. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
9. The acute phase response
10. Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells
11. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate α1-antichymotrypsin expression in human cortical astrocytes
12. Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts
13. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
14. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release
15. Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system
16. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells
17. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
18. Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei
19. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis
20. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
21. Regulation of synthesis of some proteinase inhibitors in human hepatoma cells HepG2 by cytokines, hepatocyte growth factor and retinoic acid
22. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells
23. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6
24. Signaling of type II oncostatin M receptor
25. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action
26. Cytokines which signal through the LIF receptor and their actions in the nervous system
27. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?
28. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases
29. Effects of leukemia inhibitory factor on the differentiation of astrocyte progenitor cells from embryonic mouse cerebral hemispheres
30. Interleukin-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 receptor
31. Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes
32. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase
33. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma
34. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies
35. RAP, a novel type of ER chaperone
36. The carboxyl-terminal domain of receptor-associated protein facilitates proper folding and trafficking of the very low density lipoprotein receptor by interaction with the three amino-terminal ligand-binding repeats of the receptor
37. Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways
38. LIF is an autocrine factor for sympathetic neurons
39. Leukemia inhibitory factor is an autocrine survival factor for Schwann cells
40. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: Inhibition of meningioma cell growth in vitro by recombinant oncostatin M